Form 4: Centene Corp Executive Christopher Koster Reports Stock Transactions

Centene Corp's Secretary & General Counsel, Christopher Koster, reported the disposal of 2,518 shares for tax purposes and updated holdings including stock options and phantom stock.

Summary

• Christopher Koster, Secretary & General Counsel at Centene Corp, filed a Form 4 detailing changes in his beneficial ownership of company stock.
• On December 15, 2024, 2,518 shares of common stock were disposed of to cover taxes related to vesting of restricted stock units at a price of $59.42 per share.
• Following the transaction, Koster directly owns 194,290.644 shares of common stock and indirectly owns 100 shares through his spouse.
• Koster also holds options to purchase 15,690 shares of common stock at an exercise price of $81.85, which may become exercisable after December 15, 2024, if the stock price reaches $100 for 20 consecutive trading days.
• Additionally, Koster holds 3,015.544 shares of phantom stock, which will be settled in cash or other non-company securities upon his termination or at his election.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions, which is neither positive nor negative in itself.

Future Outlook

The stock options may become exercisable if the stock price reaches $100 for 20 consecutive trading days after December 15, 2021. The phantom stock will be settled upon Mr. Koster's termination or at his election.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It provides transparency into the holdings of key personnel.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and Centene's filing is consistent with these requirements.
• The reporting of stock options, restricted stock units, and phantom stock is common among executive compensation packages in the healthcare industry, similar to companies like UnitedHealth Group and CVS Health.
• The vesting conditions for stock options, such as the stock price target of $100 for 20 consecutive days, are also typical in performance-based compensation plans.

Stakeholder Impact

• The stock transactions may have a minor impact on the overall share price, but are not expected to significantly affect shareholders.
• The disclosure provides transparency to stakeholders regarding executive compensation and ownership.

Key Dates

Keywords

Centene Corp, stock transaction, Form 4, insider trading, Christopher Koster, stock options, phantom stock, restricted stock units